Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000721748-14-000362
Filing Date
2014-04-15
Accepted
2014-04-15 11:19:13
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 mspc10k041014.htm 10-K 357947
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER OF METROSPACES, INC. PURSUANT TO SE mspc10k041014ex311.htm EX-31.1 9343
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER OF METROSPACES, mspc10k041014ex321.htm EX-32.1 3811
4 GRAPHIC image_004.gif GRAPHIC 49
5 mspc10k041041ex1016.htm EX-10.16 58693
6 GRAPHIC image_006.gif GRAPHIC 49
13 GRAPHIC image_005.gif GRAPHIC 73
14 GRAPHIC image_003.jpg GRAPHIC 21341
  Complete submission text file 0000721748-14-000362.txt   1668823

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE mspc-20131231.xml EX-101.INS 89649
8 XBRL SCHEMA FILE mspc-20131231.xsd EX-101.SCH 17375
9 XBRL CALCULATION FILE mspc-20131231_cal.xml EX-101.CAL 21515
10 XBRL DEFINITION FILE mspc-20131231_def.xml EX-101.DEF 33817
11 XBRL LABEL FILE mspc-20131231_lab.xml EX-101.LAB 105320
12 XBRL PRESENTATION FILE mspc-20131231_pre.xml EX-101.PRE 96123
Mailing Address 888 BRICKELL KEY DR. UNIT 1102 MIAMI FL 33131
Business Address 888 BRICKELL KEY DR. UNIT 1102 MIAMI FL 33131 3056000407
METROSPACES, INC. (Filer) CIK: 0001488501 (see all company filings)

EIN.: 000000000 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36220 | Film No.: 14764105
SIC: 2835 In Vitro & In Vivo Diagnostic Substances